DE69400723T2 - Verwendung von Pyridoxal-Derivaten zur Herstellung eines Arzneimittels zur Behandlung des Katarakts - Google Patents

Verwendung von Pyridoxal-Derivaten zur Herstellung eines Arzneimittels zur Behandlung des Katarakts

Info

Publication number
DE69400723T2
DE69400723T2 DE69400723T DE69400723T DE69400723T2 DE 69400723 T2 DE69400723 T2 DE 69400723T2 DE 69400723 T DE69400723 T DE 69400723T DE 69400723 T DE69400723 T DE 69400723T DE 69400723 T2 DE69400723 T2 DE 69400723T2
Authority
DE
Germany
Prior art keywords
compound
cataract
lens
cysteine
pyridoxal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69400723T
Other languages
German (de)
English (en)
Other versions
DE69400723D1 (de
Inventor
Eri Inoue
Kazumi Ogata
Shunji Sogo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of DE69400723D1 publication Critical patent/DE69400723D1/de
Application granted granted Critical
Publication of DE69400723T2 publication Critical patent/DE69400723T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69400723T 1993-04-02 1994-03-29 Verwendung von Pyridoxal-Derivaten zur Herstellung eines Arzneimittels zur Behandlung des Katarakts Expired - Fee Related DE69400723T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7649093 1993-04-02

Publications (2)

Publication Number Publication Date
DE69400723D1 DE69400723D1 (de) 1996-11-21
DE69400723T2 true DE69400723T2 (de) 1997-03-20

Family

ID=13606667

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69400723T Expired - Fee Related DE69400723T2 (de) 1993-04-02 1994-03-29 Verwendung von Pyridoxal-Derivaten zur Herstellung eines Arzneimittels zur Behandlung des Katarakts

Country Status (7)

Country Link
US (1) US5441972A (cg-RX-API-DMAC7.html)
EP (1) EP0617960B1 (cg-RX-API-DMAC7.html)
AT (1) ATE144140T1 (cg-RX-API-DMAC7.html)
CA (1) CA2120300A1 (cg-RX-API-DMAC7.html)
DE (1) DE69400723T2 (cg-RX-API-DMAC7.html)
ES (1) ES2092844T3 (cg-RX-API-DMAC7.html)
TW (1) TW268948B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
JP2002539127A (ja) 1999-03-08 2002-11-19 メディキュア インコーポレーテッド ビタミンb−6障害のためのピリドキサル類縁体
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
WO2001013900A2 (en) 1999-08-24 2001-03-01 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
WO2001064692A1 (en) 2000-02-29 2001-09-07 Medicure International Inc. Cardioprotective phosphonates and malonates
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
JP2004502757A (ja) 2000-07-07 2004-01-29 メディキュア インターナショナル インコーポレイテッド ピリドキシンおよびピリドキサール類縁体:心血管系治療薬
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
CA2570048A1 (en) * 2004-07-07 2006-01-12 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
CA2585165A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
JP2009517411A (ja) * 2005-11-28 2009-04-30 メディキュア インターナショナル インコーポレーテッド 心血管及び関連病状の処置のための調剤

Also Published As

Publication number Publication date
DE69400723D1 (de) 1996-11-21
ES2092844T3 (es) 1996-12-01
CA2120300A1 (en) 1994-10-03
TW268948B (cg-RX-API-DMAC7.html) 1996-01-21
EP0617960B1 (en) 1996-10-16
EP0617960A1 (en) 1994-10-05
ATE144140T1 (de) 1996-11-15
US5441972A (en) 1995-08-15

Similar Documents

Publication Publication Date Title
DE69628353T2 (de) Benzopyran enthaltende Verbindungen und deren Prodrugformen
DE69733353T2 (de) Immunsuppressive wirkstoffe und verfahren
DE3877406T2 (de) Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
US5441972A (en) Pharmaceutical use of pyridoxal derivative
DE69909209T2 (de) Pyrimidinon-derivate, diese verbindungen enthaltenden pharmazeutische zubereitungen und verfharen zu ihrer herstellung
DE3877386T2 (de) Antikrebsverbindungen.
DE69805334T2 (de) Derivate des vitamin e
DE69020781D1 (de) Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus.
DE68910211T2 (de) Estramustin-ester.
DE2359536A1 (de) 2,6-diaminonebularinderivate
DE69001722T2 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
DE69122812T2 (de) Glutathionderivat
JPS60190742A (ja) フエニルメチルフエノキシ化合物その製造法および医薬組成物
US2987442A (en) Method of treating hypertension with [2-(2, 6-dimethylphenoxy)-propyl]-trimethyl ammonium salts
DE69509091T2 (de) Salze von 2-[(2,6-dichlorophenyl)amin]phenylacetoxyessigsäure mit organischen basischen kationen
DE69326479T2 (de) Methotrexat-derivate
DE69413333T2 (de) Benzospiroalken-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69600714T2 (de) Antiallergische Zusammensetzung enthaltend eine Phosphorsäurediester-Verbindung
DE3414049C2 (cg-RX-API-DMAC7.html)
DE69518258T2 (de) Kortikoidderivate und pharmazeutische und kosmetische Zusammensetzungen
DE60005154T2 (de) S-nitrosothiole als agentien zur behandlung von fehlfunktionen des kreislaufs
US3590039A (en) N - (alpha,alpha,alpha,alpha',alpha',alpha' -hexafluoro - 3,5 - xylyl) anthranilic acid and salts thereof
DE2236876B2 (de) N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel
US5087628A (en) 4,4'-[9H-fluoren-9-ylidenebis (methylene)]bispyrimidine for treating neurological disorders
DE3415666A1 (de) Neue acylaminophenolderivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee